BioCatalyst

zongertinib, pembrolizumab, cisplatin, carboplatin — catalyst calendar

1 verified catalyst event(s) referencing zongertinib, pembrolizumab, cisplatin, carboplatin, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-02
in 2mo
ESTIMATED
 READOUT
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People Wi
Phase 3 · Lung Cancer, Non-squamous, Non-small Cell
 Boehringer Ingelheim zongertinib, pembrolizumab, cisplatin, c ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.